BioMed Realty Trust Announces Increase in Quarterly Common Stoc... (

BioMed Realty Trust Announces Increase in Quarterly Common Stock Dividend

Date:3/17/2008

- Declares Preferred Stock Dividend -

SAN DIEGO, Calif., March 17 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a first quarter 2008 dividend of $0.335 per share of common stock, an 8.1% increase over the company's previous quarterly dividend of $0.31 per share. The increased dividend is equivalent to an annualized dividend of $1.34 per common share.

BioMed also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from January 16, 2008 through April 15, 2008.

The dividends are payable on April 15, 2008 to stockholders of record at the close of business on March 31, 2008.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty Trust owns or has interests in 68 properties, representing 104 buildings with approximately 8.5 million rentable square feet, as well as approximately 1.9 million square feet of development in progress. These properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at http://www.biomedrealty.com. <
'/>"/>

0

GOOD

Page: 1 2
Related biology technology :

1. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
2. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
3. LifeNet Health(R) Unveils New Biomedical Spine Implant
4. MIT researcher addresses biomedical engineering challenges
5. mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical
6. BioMed Realty Trust Announces Tax Treatment of 2007 Distributions
7. BioMed Realty Trust To Report 2007 Fourth Quarter and Year-End Results
8. Bookham to Enter Biomedical Illumination Market
9. BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board
10. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
11. New NIST mini-sensor may have biomedical and security applications

Post Your Comments:

BioMed Realty Trust Announces Increase in Quarterly Common Stoc...( - Declares Preferr...)